---
category: news
title: "Enzolytics Announces the Discovery and Patenting of Eleven Newly Identified Conserved Target Sites on the SARS-CoV-2 Virus (Coronavirus) - MarketWatch"
excerpt: "(OTC Markets \"ENZC\" or the \"Company\") today announced it has identified eleven conserved, expectedly immutable sites (epitopes) on the Coronavirus against which it is producing targeted anti-SARS-CoV-2 monoclonal antibodies."
publishedDateTime: 2021-02-22T10:30:00Z
originalUrl: "https://www.marketwatch.com/press-release/enzolytics-announces-the-discovery-and-patenting-of-eleven-newly-identified-conserved-target-sites-on-the-sars-cov-2-virus-coronavirus-2021-02-22"
webUrl: "https://www.marketwatch.com/press-release/enzolytics-announces-the-discovery-and-patenting-of-eleven-newly-identified-conserved-target-sites-on-the-sars-cov-2-virus-coronavirus-2021-02-22"
type: article
quality: 14
heat: 14
published: false

provider:
  name: MarketWatch
  domain: marketwatch.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/marketwatch.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png"
    width: 1200
    height: 630
    isCached: true

related:
  - title: "Enzolytics Announces the Discovery and Patenting of Eleven Newly Identified Conserved Target Sites on the SARS-CoV-2 Virus (Coronavirus)"
    excerpt: "Production of Monoclonal Antibodies Targeting These Sites Is in Process in the Company’s Texas Lab COLLEGE STATION, TX / ACCESSWIRE / February 22, 2021 / Enzolytics, Inc. (OTC Markets “ENZC” or the “Company”) today announced it has identified eleven conserved,"
    publishedDateTime: 2021-02-22T15:45:00Z
    webUrl: "https://apnews.com/press-release/accesswire/science-business-technology-public-health-government-regulations-0b52f59f596faaf39676631741de8d24"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 0

secured: "1GM1BdS1QkpnnYxPBw26egdjZFbw2Ispjj3QrG8JMfjbn1HkPO8QmlqXoMxp5YUQndlnJDT8mAIcMP/K3Ss4gBSKKQn/ynGJbiEIujW2drMQGiSC6B3rUEOPW7+IKpREEcFhZPTOAW6JLFTtNtvcU4qsQczie1jwEjrRp0riILykB2QuSLUhqHS7gLxA111kIKfPPIUzMI51jEP2WE/cAjWBZMFhM2up7ivySV4qoSnzwXJ5zAzIQw/1Z+CrOPtfseata16ZDf5TqKdfeD5tCr/Wi0G+6VLHW8x6f50m2jM73DeDkk6W5+rrllSq5DwKbKXLsGQDFIyDaBRWvu7bT7AtRCQa8faqclu2OSn+kas=;VI2fMrpDMW5KRH2y2Hfu7A=="
---

